Results of the Europlasma General Meeting of September 2, 2026

Europlasma's ordinary and extraordinary general meeting was held on September 2, 2026, in Pessac. Shareholders present or represented constituted a 100% quorum. Twelve of the thirteen proposed resolutions were approved. These included the company and consolidated financial statements for 2025 and financial delegations to the Board of Directors. The seventh resolution, related to specific provisions of the French Commercial Code, was rejected.

The voting results and other related documents are available on the company's website, in the section dedicated to General Meetings. Europlasma also reminds investors of the risks associated with its financing through convertible bonds, particularly in terms of potential dilution.